ReleaseWire

As Physical Therapy Month concludes, the Kansas Physical Therapy Association (KPTA) begins its first-ever anti-opioid campaign, timed to bring new awareness to the state's families over the holidays.

Compounding pharmacy in Studio City, ABC Compounding Pharmacy, prides itself on putting patient care first. To ensure that customer care is a top priority, they provide quality service and customized prescriptions all at a low, convenient price. Compounding pharmacy in Studio City pharmacists will assist patients with their customized medication and make sure that it will be specified to their exact needs.

America has a problem with heroin abuse that the American Medical Association (AMA) says is due to medical doctors over-prescribing OxyContin. The makers of OxyContin, Purdue Pharma, was fined more than $600 million for misleading doctors and patients about a decade ago about how addictive this opioid-based medication can be.

TheraKine Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 9474715, which enables innovative methods for locally injectable sustained release formulations of biologic and small molecule drugs with high concentration and superior injectability.

A one stop shop for health care solutions in Australia, Star Discount Chemist, is offering free home delivery services for patients incapable to visit their pharmacy for medications. This free service is available for the customers who have registered their scripts with the store. Through their home delivery services, patients can be rest assured of getting their medicines delivered to their door, within the right time and as per the doctor's prescriptions. So, those who have still not registered their scripts with Star Discount Chemist can contact their friendly staff over phone at 08 8443 7955, or fill in a simple query form present on their official website, StarDiscountChemist.com.au.

Sernova Corp., a clinical stage company developing disruptive regenerative medicine technologies for the long-term treatment of chronic diseases including diabetes and hemophilia and CTI Clinical Trial and Consulting Services (CTI), are pleased to announce their collaboration on regulatory matters respecting Sernova's Cell Pouch System(TM), a novel implantable and scalable medical device that when combined with therapeutic cells, may provide a convenient, safe and effective long-term therapeutic option for patients with chronic diseases such as insulin-dependent diabetes who seek to improve their quality of life.

The Los Angeles Compounding Pharmacy, ABC Pharmacy, is proficient at creating compounded medications. With the use of technology, the Los Angeles Compounding Pharmacy's specialists are able to customize medication into injections, pills or inhalants. To provide the most accurate medication for each patient, the pharmacists take the time to learn about their preferences, dislikes and current health issues.  The staff at ABC Pharmacy have dedicated their careers to providing quality care and products to everyone who enters their store.

Highly rated Santa Monica compounding pharmacy ABC Pharmacy of Beverly Hills offers exceptional pharmaceutical care to all patients. The Santa Monica compounding pharmacy remains competitive with chain pharmacies by creating individualized prescriptions. They are able to meet patients' specialized needs with every compounded medication.

Hypercholesterolemia is an inherited condition that results in high levels of total cholesterol. Cholesterol is a fatty substance that occurs naturally in the body that can be dangerous when it builds up on artery walls. Hypercholesterolemia can cause atherosclerosis and increase your risk of heart disease called coronary artery disease. Human blood cholesterol includes of high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and very low-density lipoprotein (VLDL) cholesterol.

Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in which blood sugar levels goes extremely high over a prolonged period. Antidiabetics are the medicines developed to stabilize and control blood glucose (sugar) levels amongst diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin pramlintide (Amylin), GLP-1 receptor agonists such as byetta and victoza are the different types of antidiabetics drugs. The global antidiabetics market is driven by increasing prevalence of diabetes mellitus.

Insulin regulates metabolism by creating the pancreas that allows your body to use glucose from carbohydrates in the food. Insulin helps to keep your blood sugar level from getting too high or too low. Insulin enables the entry of glucose in the cell and maintains level of blood glucose. In diabetes treatment, patient need insulin injections to allow body to process sugar and avoid complications from hyperglycemia.

A smartphone enabled personal safe, iKeyp helps prevent the prescription medication abuse by keeping the medication private and secure. Founder Jeffrey Hermann is looking to raise $50,000 via Indiegogo for the initial production run of iKeyp.

GlobalData's clinical trial report, "Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Acute Myeloid Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Relapsed Acute Myeloid Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Bulimia Nervosa Global Clinical Trials Review, H2, 2016" provides an overview of Bulimia Nervosa clinical trials scenario. This report provides top line data relating to the clinical trials on Bulimia Nervosa. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GlobalData's clinical trial report, "Cerebellar Ataxia Global Clinical Trials Review, H2, 2016" provides an overview of Cerebellar Ataxia clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebellar Ataxia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

M Pharmaceutical Inc., (the "Company" or "M Pharma"), is pleased to announce that it has engaged Camargo Pharmaceutical Services, in order to help C-103 is a novel formulation of Orlistat, patented until 2030 in the United States. Orlistat is FDA-approved for weight management and sold by Roche as Xenical® (prescription) and by GlaxoSmithKline as alli® (over-the-counter). Orlistat is the best-selling weight loss medication of all time with peak sales over $900 million in 2007. C-103 is intended to maintain the efficacy of Orlistat while minimizing its socially unacceptable side effects.

For nearly three decades, Synthecon, Inc. has been a leader in 3D cell culture technology through innovating and exploring the potential of the rotary cell culture system as it applies to tissue engineering, stem cell culture, tumor spheroid formation, host-pathogen studies and more. Their role in research has been absolutely vital to these and a broad range of other applications, but particularly regarding those relating to animal and human health.

M Pharmaceutical Inc., (the "Company" or "M Pharma"), is announcing that the Company has entered into a letter of intent to acquire from ToConceive LLC., a private pharmaceutical company, the rights to an FDA approved women's health product, used as a natural conception lubricant as an infertility treatment. This acquisition is subject to further due diligence and stock exchange approval, and would see the Company issue 20 million shares and agree to pay a 5% royalty on sales.

We need your help! We are looking for project personnel from both Owners and Contractors with at least 10 years of industry experience, with significant involvement in Front End Engineering Design (FEED) of large industrial projects.

Today, DisruptiveRx™ and MAD Event Management announced the first blockchain conference series exclusively for the bio/pharmaceutical industry. The first in the series will take place on November 16, 2016 in Edison, NJ – www.RXBlockchainBootcamp.com.

CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

COS 2016, the 4th annual Clinical Outsourcing Strategies Symposium will be held in Brussels, Belgium on the 20th & 21st of October 2016. Sixteen prestigious professionals within the pharmaceutical industry have confirmed their speaking positions. With a capacity of 150 participants, COS will be held along with the Clinical Trial Supplies Network (CTS) – 2nd Annual Symposium on the same dates and venue.

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).

Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring Investigational Medicinal Products (IMPs) and NON-Investigational Medicinal Products (NIMPs) based on logistics, distribution, packaging, labelling and storage. Speakers include senior experts from the Top 50 Bio/Pharma companies worldwide, and high caliper colleagues from Small to Medium Size Bio/Pharma/Biotech companies globally. Brussels Clinical Trial Supply network is co-housed with the 4th Annual Clinical Outsourcing Strategies Symposium (COS 2016).